Pizotifen is a medication used to prevent migraines and is often subject to impurities. These impurities can be unwanted byproducts of the manufacturing process, or they can be degradation products that form over time. These impurities can impact the efficacy and safety of the drug and must be monitored and controlled to ensure its quality. Identification and quantification of Pizotifen impurities are important for regulatory compliance and quality control purposes.